Reporting Adverse Events

The safe use of CAMZYOS is of paramount importance. As part of our ongoing safety monitoring, Bristol Myers Squibb wishes to be informed of adverse events that have occurred during use of CAMZYOS. Please report any adverse events and pregnancies to: BMS Medical Information Call Center (Telephone: 0800-666-132, or email: MedInfo.Taiwan@bms.com). If the event meets the reporting criteria outlined in the Regulations for Reporting Serious Adverse Drug Reactions of Medicaments, please report the event to the National Adverse Drug Reaction Reporting System (https://adr.fda.gov.tw/logon) in accordance with the Regulations. 

If you have any questions regarding CAMZYOS or require more information, please contact Bristol Myers Squibb.